Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 41

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT02248571Phase 4Completed
Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With Bevacizumab
Breast Cancer RecurrentHER2/Neu-negative Carcinoma of BreastHormone Receptor Positive Malignant Neoplasm of Breast
PrincipalinvestigatorStart date: 2014-08-01

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Lea Baer, MD

Stony Brook University

Related
1 trials

Shared therapeutic areas:

Hormone Receptor Positive Malignant Neoplasm of Breast
Similarity Score10%

Takayuki Ueno, MD,PhD

Cancer Institute Hospital of JFCR, Department Director, Breast Surgical Oncology Department

Related
1 trials

Shared therapeutic areas:

Hormone Receptor Positive Malignant Neoplasm of Breast
Similarity Score10%

Masakazu Toi, MD,PhD

Kyoto University, Professor of Breast Surgery Department

Related
1 trials

Shared therapeutic areas:

Hormone Receptor Positive Malignant Neoplasm of Breast
Similarity Score10%

Binghe Xu, M.D.

Chinese Academy of Medical Sciences

Related
3 trials

Shared therapeutic areas:

Breast Cancer Recurrent
Similarity Score10%

Malene Hildebrandt, M.D.

Dept. Nuclear Medicine, Odense University Hospital

Related
1 trials

Shared therapeutic areas:

Breast Cancer Recurrent
Similarity Score10%

Guohui Han, M.D.

Tumor Hospital of Shanxi Province

Related
1 trials

Shared therapeutic areas:

Breast Cancer Recurrent
Similarity Score10%

Alison Stopeck, MD

Stony Brook University

Related
4 trials

Shared therapeutic areas:

Hormone Receptor Positive Malignant Neoplasm of Breast
Similarity Score10%

Anthony Kong

Clinical reader and honorary NHS consultant in clinical oncology

Related
2 trials

Shared therapeutic areas:

Breast Cancer Recurrent
Similarity Score10%

Wonshik Han, MD PhD

Seoul National University Hospital

Related
1 trials

Shared therapeutic areas:

Hormone Receptor Positive Malignant Neoplasm of Breast
Similarity Score10%

Louis WC Chow, MD,PhD

Organisation for Oncology and Translational Research (OOTR)

Related
1 trials

Shared therapeutic areas:

Hormone Receptor Positive Malignant Neoplasm of Breast
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02248571Phase 4PrincipalInvestigator

Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With Bevacizumab

Breast Cancer RecurrentHER2/Neu-negative Carcinoma of BreastHormone Receptor Positive Malignant Neoplasm of Breast
Completed

All 1 trials loaded